{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:37:45Z","timestamp":1790447865373,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.071","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T02:26:13Z","timestamp":1604456773000},"page":"7897-7904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4711-5767","authenticated-orcid":false,"given":"Stephen N.","family":"Crooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel D.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-4457","authenticated-orcid":false,"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25\u201326","key":"10.1016\/j.vaccine.2020.10.071_b0005","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/S0264-410X(01)00073-1","article-title":"Rubella eradication","volume":"19","author":"Plotkin","year":"2001","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2020.10.071_b0010","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.vaccine.2014.03.097","article-title":"Healthcare providers as sources of vaccine-preventable diseases","volume":"32","author":"Sydnor","year":"2014","journal-title":"Vaccine"},{"issue":"9984","key":"10.1016\/j.vaccine.2020.10.071_b0015","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","article-title":"Rubella","volume":"385","author":"Lambert","year":"2015","journal-title":"Lancet"},{"issue":"RR-04","key":"10.1016\/j.vaccine.2020.10.071_b0020","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR"},{"issue":"39","key":"10.1016\/j.vaccine.2020.10.071_b0025","first-page":"855","article-title":"Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000\u20132018","volume":"68","author":"Grant","year":"2019","journal-title":"MMWR"},{"issue":"20","key":"10.1016\/j.vaccine.2020.10.071_b0030","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.vaccine.2012.02.062","article-title":"Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad((R))) in infants from 9 months of age","volume":"30","author":"Vesikari","year":"2012","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2020.10.071_b0035","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1016\/j.vaccine.2012.08.057","article-title":"Measles, mumps, and rubella virus vaccine (M-M-RII): a review of 32 years of clinical and postmarketing experience","volume":"30","author":"Lievano","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.071_b0040","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"200","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.071_b0045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2020.10.071_b0050","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1016\/j.vaccine.2018.08.010","article-title":"Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults","volume":"36","author":"McLean","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.071_b0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1128\/CVI.00032-07","article-title":"Humoral immune response after primary rubella virus infection and after vaccination","volume":"14","author":"Vauloup-Fellous","year":"2007","journal-title":"Clin Vaccine Immunol."},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.071_b0060","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.vaccine.2019.11.004","article-title":"Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age","volume":"38","author":"Haralambieva","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.071_b0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.0022-202X.2005.23841.x","article-title":"Chemokines: key players in innate and adaptive immunity","volume":"125","author":"Esche","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.071_b0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.071_b0075","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.4049\/jimmunol.1602000","article-title":"Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm","volume":"198","author":"Jain","year":"2017","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.071_b0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00439-009-0763-1","article-title":"Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes","volume":"127","author":"Ovsyannikova","year":"2010","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.071_b0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00251-010-0423-6","article-title":"SNP\/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine","volume":"62","author":"Dhiman","year":"2010","journal-title":"Immunogenetics"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2020.10.071_b0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00251-014-0776-3","article-title":"Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients","volume":"66","author":"Kennedy","year":"2014","journal-title":"Immunogenetics"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.071_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099997","article-title":"Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination","volume":"9","author":"Haralambieva","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.071_b0100","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00439-014-1471-z","article-title":"Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination","volume":"133","author":"Kennedy","year":"2014","journal-title":"Hum Genet"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.071_b0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00251-014-0796-z","article-title":"Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines","volume":"66","author":"Ovsyannikova","year":"2014","journal-title":"Immunogenetics"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.071_b0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00251-015-0864-z","article-title":"Single nucleotide polymorphisms\/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children","volume":"67","author":"Ovsyannikova","year":"2015","journal-title":"Immunogenetics"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.071_b0115","doi-asserted-by":"crossref","first-page":"2154S","DOI":"10.3945\/jn.109.105312","article-title":"Landscape analysis of interactions between nutrition and vaccine responses in children","volume":"139","author":"Savy","year":"2009","journal-title":"J Nutrition"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2020.10.071_b0120","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1093\/cid\/ciu611","article-title":"Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challenges","volume":"59","author":"Hoest","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.071_b0125","first-page":"201","article-title":"Genetic variation in the response to vaccination","volume":"10","author":"Kimman","year":"2007","journal-title":"Community Genet."},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.071_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.smim.2013.04.007","article-title":"Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century","volume":"25","author":"Poland","year":"2013","journal-title":"Semin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.071_b0135","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/j.celrep.2019.05.053","article-title":"Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization","volume":"27","author":"O'Connor","year":"2019","journal-title":"Cell Rep"},{"issue":"36","key":"10.1016\/j.vaccine.2020.10.071_b0140","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized vaccinology: A review","volume":"36","author":"Poland","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.071_b0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-61779-325-7_16","article-title":"Detection of vaccinia virus-specific IFNgamma and IL-10 secretion from human PBMCs and CD8(+) T cells by ELISPOT","volume":"792","author":"Umlauf","year":"2012","journal-title":"Methods Molec Biol"},{"issue":"29","key":"10.1016\/j.vaccine.2020.10.071_b0150","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2019.05.049","article-title":"Seroprevalence and durability of rubella virus antibodies in a highly immunized population","volume":"37","author":"Crooke","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.071_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2009.12.002","article-title":"Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees","volume":"50","author":"Dhiman","year":"2010","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.071_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12026-013-8475-y","article-title":"Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts","volume":"58","author":"Lambert","year":"2013","journal-title":"Immunol Res"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.071_b0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.imbio.2008.01.006","article-title":"Effective collaboration between IL-4 and IL-21 on B cell activation","volume":"213","author":"Saito","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2020.10.071_b0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fimmu.2014.00065","article-title":"Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage","volume":"5","author":"Moens","year":"2014","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.071_b0175","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.4049\/jimmunol.1300749","article-title":"IL-4 regulates Bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints","volume":"192","author":"Granato","year":"2014","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.071_b0180","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20112142","article-title":"Macrophages induce differentiation of plasma cells through CXCL10\/IP-10","volume":"209","author":"Xu","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2020.10.071_b0185","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.139.9.2970","article-title":"Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1","volume":"139","author":"Jelinek","year":"1987","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2020.10.071_b0190","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1073\/pnas.91.15.7007","article-title":"Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells","volume":"91","author":"Boussiotis","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5995","key":"10.1016\/j.vaccine.2020.10.071_b0195","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/312641a0","article-title":"Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells","volume":"312","author":"Mingari","year":"1984","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.071_b0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/00365540152029945","article-title":"Elevated serum levels of interleukin-10 in children with acute rubella infection","volume":"33","author":"Akaboshi","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.071_b0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09629350310001599639","article-title":"Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination","volume":"12","author":"Pukhalsky","year":"2003","journal-title":"Mediators Inflamm."},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.071_b0210","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1128\/IAI.73.11.7620-7628.2005","article-title":"Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection","volume":"73","author":"Roberts","year":"2005","journal-title":"Infect Immun"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.10.071_b0215","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/diabetes.54.suppl_2.S11","article-title":"Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)","volume":"54","author":"Herder","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.071_b0220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ajcn\/84.3.505","article-title":"Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study","volume":"84","author":"Warnberg","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.071_b0225","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s10753-013-9620-4","article-title":"Adipocytokine levels in obese and non-obese subjects: an observational study","volume":"36","author":"Derosa","year":"2013","journal-title":"Inflammation"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.071_b0230","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","article-title":"The major inflammatory mediator interleukin-6 and obesity","volume":"58","author":"Eder","year":"2009","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.071_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010024","article-title":"Obesity-Induced TNFalpha and IL-6 Signaling: The Missing Link between Obesity and Inflammation-Driven Liver and Colorectal Cancers","volume":"11","author":"Kern","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.071_b0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2009.0068","article-title":"Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity","volume":"22","author":"Tosh","year":"2009","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2020.10.071_b0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2009.12.002","article-title":"Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in health vaccinees","volume":"50","author":"Dhiman","year":"2010","journal-title":"Cytokine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:48:17Z","timestamp":1759402097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":49,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20313918"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}